Raphael Jacob, Abedat Suzan, Rivo Julia, Meir Karen, Beeri Ronen, Pugatsch Thea, Zuo Zhiyi, Gozal Yaacov
Department of Anesthesiology, the Heart Institute, Hebrew University, Jerusalem, Israel.
J Pharmacol Exp Ther. 2006 Jul;318(1):186-94. doi: 10.1124/jpet.105.100537. Epub 2006 Mar 21.
We tested whether isoflurane preconditioning inhibits cardiomyocyte apoptosis and evaluated the role of the phosphatidylinositol-3-kinase (PI3K)/Akt pathway in anesthetic preconditioning and determined whether PI3K/Akt signaling modulates the expression of pro- and antiapoptotic proteins in anesthetic preconditioning. Six-month-old New Zealand rabbits subjected to 40 min of myocardial ischemia followed by 180 min of reperfusion were assigned to the following groups: ischemia-reperfusion (I/R), isoflurane preconditioning and isoflurane plus PI3K inhibitors, wortmannin and 2-(4-morpholinyl)-8-phenyl-4H-l-benzopyran-4-one (LY294002) (0.6 and 0.3 mg/kg i.v., respectively). Sham-operated, wortmannin+I/R, wortmannin+sham, LY294002+I/R, and LY294002+sham groups were also included. Infarct size was assessed by triphenyltetrazolium chloride staining. Apoptosis was evaluated by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling and activated caspase-3 assays. Akt phosphorylation, Bax, Bcl-2, Bad, and phosphorylated Bad (phospho-Bad) expression was assessed by immunoblotting. Isoflurane preconditioning reduced infarct size compared with the I/R group: 22+/-4 versus 41+/-5% (p<0.05). The percentage of apoptotic cells decreased in the isoflurane group (3.8+/-1.2%) compared with the I/R group (12.4+/-1.6%; p<0.05). These results were also confirmed by the activated caspase-3 assay. Wortmannin and LY294002 inhibited the effects of isoflurane. Myocardial infarction increased to 44+/-3 and 45+/-2% and the percentage of apoptotic cells was 11.9+/-2.1 and 11.7+/-3.3%, respectively. Akt phosphorylation and Bcl-2 and phospho-Bad expression increased after isoflurane preconditioning, whereas Bax expression decreased. These effects were inhibited by wortmannin and LY294002. The data indicate that isoflurane preconditioning reduces infarct size and myocardial apoptosis after I/R. Activation of PI3K and modulation of the expression of pro- and antiapoptotic proteins may play a role in isoflurane-induced myocardial protection.
我们检测了异氟烷预处理是否能抑制心肌细胞凋亡,并评估磷脂酰肌醇-3-激酶(PI3K)/蛋白激酶B(Akt)信号通路在麻醉预处理中的作用,还确定了PI3K/Akt信号传导是否能调节麻醉预处理中促凋亡蛋白和抗凋亡蛋白的表达。将6月龄新西兰兔进行40分钟心肌缺血及随后180分钟再灌注,分为以下几组:缺血-再灌注组(I/R)、异氟烷预处理组、异氟烷加PI3K抑制剂渥曼青霉素和2-(4-吗啉基)-8-苯基-4H-1-苯并吡喃-4-酮(LY294002)组(分别静脉注射0.6和0.3mg/kg)。还设立了假手术组、渥曼青霉素+I/R组、渥曼青霉素+假手术组、LY294002+I/R组和LY294002+假手术组。通过氯化三苯基四氮唑染色评估梗死面积。通过末端脱氧核苷酸转移酶介导的dUTP缺口末端标记法和活化的半胱天冬酶-3检测评估细胞凋亡。通过免疫印迹法评估Akt磷酸化、Bax、Bcl-2、Bad和磷酸化Bad(磷酸化-Bad)的表达。与I/R组相比,异氟烷预处理可减小梗死面积:分别为22±4%和41±5%(p<0.05)。与I/R组(12.4±1.6%)相比,异氟烷组凋亡细胞百分比降低(3.8±1.2%;p<0.05)。活化的半胱天冬酶-3检测也证实了这些结果。渥曼青霉素和LY294002抑制了异氟烷的作用。心肌梗死面积分别增加到44±3%和45±2%,凋亡细胞百分比分别为11.9±2.1%和11.7±3.3%。异氟烷预处理后Akt磷酸化、Bcl-2和磷酸化-Bad表达增加,而Bax表达降低。这些作用被渥曼青霉素和LY294002抑制。数据表明,异氟烷预处理可减小I/R后的梗死面积并减少心肌细胞凋亡。PI3K的激活以及促凋亡蛋白和抗凋亡蛋白表达的调节可能在异氟烷诱导的心肌保护中起作用。